Suppr超能文献

阻断Chk1表达可诱导细胞凋亡并消除G2期检查点机制。

Blocking Chk1 expression induces apoptosis and abrogates the G2 checkpoint mechanism.

作者信息

Luo Y, Rockow-Magnone S K, Kroeger P E, Frost L, Chen Z, Han E K, Ng S C, Simmer R L, Giranda V L

机构信息

Department 47S AP9A, Cancer Research, Pharmaceutical Products Division, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA.

出版信息

Neoplasia. 2001 Sep-Oct;3(5):411-9. doi: 10.1038/sj.neo.7900175.

Abstract

Checkpoint kinase 1 (Chk1) is a checkpoint gene that is activated after DNA damage. It phosphorylates and inactivates the Cdc2 activating phosphatase Cdc25C. This in turn inactivates Cdc2, which leads to G2/M arrest. We report that blocking Chk1 expression by antisense or ribozymes in mammalian cells induces apoptosis and interferes with the G2/M arrest induced by adriamycin. The Chk1 inhibitor UCN-01 also blocks the G2 arrest after DNA damage and renders cells more susceptible to adriamycin. These results indicate that Chk1 is an essential gene for the checkpoint mechanism during normal cell proliferation as well as in the DNA damage response.

摘要

关卡激酶1(Chk1)是一种在DNA损伤后被激活的关卡基因。它使细胞分裂周期蛋白2(Cdc2)激活磷酸酶Cdc25C磷酸化并使其失活。这进而使Cdc2失活,导致G2/M期阻滞。我们报告称,在哺乳动物细胞中通过反义核酸或核酶阻断Chk1表达会诱导细胞凋亡,并干扰阿霉素诱导的G2/M期阻滞。Chk1抑制剂UCN - 01也会阻断DNA损伤后的G2期阻滞,并使细胞对阿霉素更敏感。这些结果表明,Chk1是正常细胞增殖以及DNA损伤反应过程中关卡机制的必需基因。

相似文献

1
Blocking Chk1 expression induces apoptosis and abrogates the G2 checkpoint mechanism.
Neoplasia. 2001 Sep-Oct;3(5):411-9. doi: 10.1038/sj.neo.7900175.
8
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.
J Biol Chem. 2000 Feb 25;275(8):5600-5. doi: 10.1074/jbc.275.8.5600.
9
Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
J Biol Chem. 2003 Jun 13;278(24):21767-73. doi: 10.1074/jbc.M300229200. Epub 2003 Apr 3.

引用本文的文献

2
Platinum Complexes in Colorectal Cancer and Other Solid Tumors.
Cancers (Basel). 2021 Apr 25;13(9):2073. doi: 10.3390/cancers13092073.
3
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia.
Cancer Res. 2021 May 15;81(10):2666-2678. doi: 10.1158/0008-5472.CAN-20-1504. Epub 2021 Jan 7.
4
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo.
Sci Rep. 2019 Mar 5;9(1):3617. doi: 10.1038/s41598-019-40218-0.
6
Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.
Am J Cancer Res. 2016 Oct 1;6(10):2129-2139. eCollection 2016.
7
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy.
Mol Cell Oncol. 2015 Feb 23;2(4):e1012976. doi: 10.1080/23723556.2015.1012976. eCollection 2015 Oct-Dec.
8
Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition.
BMC Cancer. 2015 May 21;15:422. doi: 10.1186/s12885-015-1387-6.
9
Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.
Future Oncol. 2013 Feb;9(2):219-33. doi: 10.2217/fon.12.185.
10
Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection.
PLoS Pathog. 2012;8(8):e1002898. doi: 10.1371/journal.ppat.1002898. Epub 2012 Aug 30.

本文引用的文献

2
Positive regulation of Wee1 by Chk1 and 14-3-3 proteins.
Mol Biol Cell. 2001 Mar;12(3):551-63. doi: 10.1091/mbc.12.3.551.
3
Nuclear exclusion of Cdc25 is not required for the DNA damage checkpoint in fission yeast.
Curr Biol. 2001 Jan 9;11(1):50-4. doi: 10.1016/s0960-9822(00)00026-9.
7
Rapid destruction of human Cdc25A in response to DNA damage.
Science. 2000 May 26;288(5470):1425-9. doi: 10.1126/science.288.5470.1425.
9
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.
J Biol Chem. 2000 Feb 25;275(8):5600-5. doi: 10.1074/jbc.275.8.5600.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验